 | • レポートコード：MRC2312MG11158 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、70ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の口腔乾燥症治療薬市場規模と予測を収録しています。・世界の口腔乾燥症治療薬市場：売上、2018年-2023年、2024年-2029年 ・世界の口腔乾燥症治療薬市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の口腔乾燥症治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「OTC」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 口腔乾燥症治療薬のグローバル主要企業は、GlaxoSmithKline plc、 Church & Dwight Co., Inc.、 Colgate-Palmolive Company、 Hikma Pharmaceuticals PLC、 Pendopharm、 Sun Pharmaceuticals Industries Ltd.、 Lupin Pharmaceuticals, Inc.、 Pfizer, Inc.、 Parnell Pharmaceuticals, Inc.、 Acacia Pharma、 OraCoatなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、口腔乾燥症治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の口腔乾燥症治療薬市場：タイプ別、2018年-2023年、2024年-2029年 世界の口腔乾燥症治療薬市場：タイプ別市場シェア、2022年 ・OTC、処方薬 世界の口腔乾燥症治療薬市場：用途別、2018年-2023年、2024年-2029年 世界の口腔乾燥症治療薬市場：用途別市場シェア、2022年 ・病院、診療所、その他 世界の口腔乾燥症治療薬市場：地域・国別、2018年-2023年、2024年-2029年 世界の口腔乾燥症治療薬市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における口腔乾燥症治療薬のグローバル売上、2018年-2023年 ・主要企業における口腔乾燥症治療薬のグローバル売上シェア、2022年 ・主要企業における口腔乾燥症治療薬のグローバル販売量、2018年-2023年 ・主要企業における口腔乾燥症治療薬のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 GlaxoSmithKline plc、 Church & Dwight Co., Inc.、 Colgate-Palmolive Company、 Hikma Pharmaceuticals PLC、 Pendopharm、 Sun Pharmaceuticals Industries Ltd.、 Lupin Pharmaceuticals, Inc.、 Pfizer, Inc.、 Parnell Pharmaceuticals, Inc.、 Acacia Pharma、 OraCoat ************************************************************* ・調査・分析レポートの概要 口腔乾燥症治療薬市場の定義 市場セグメント 世界の口腔乾燥症治療薬市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の口腔乾燥症治療薬市場規模 世界の口腔乾燥症治療薬市場規模：2022年 VS 2029年 世界の口腔乾燥症治療薬市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの口腔乾燥症治療薬の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の口腔乾燥症治療薬製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：OTC、処方薬 口腔乾燥症治療薬のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、診療所、その他 口腔乾燥症治療薬の用途別グローバル売上・予測 ・地域別市場分析 地域別口腔乾燥症治療薬市場規模 2022年と2029年 地域別口腔乾燥症治療薬売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） GlaxoSmithKline plc、 Church & Dwight Co., Inc.、 Colgate-Palmolive Company、 Hikma Pharmaceuticals PLC、 Pendopharm、 Sun Pharmaceuticals Industries Ltd.、 Lupin Pharmaceuticals, Inc.、 Pfizer, Inc.、 Parnell Pharmaceuticals, Inc.、 Acacia Pharma、 OraCoat ... |
This research report provides a comprehensive analysis of the Xerostomia Therapeutics market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Xerostomia Therapeutics market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Xerostomia Therapeutics, challenges faced by the industry, and potential opportunities for market players.
The global Xerostomia Therapeutics market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Xerostomia Therapeutics market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Xerostomia Therapeutics market. Additionally, the growing consumer demand present avenues for market expansion.
The global Xerostomia Therapeutics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Xerostomia Therapeutics market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Xerostomia Therapeutics market.
Market Overview: The report provides a comprehensive overview of the Xerostomia Therapeutics market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., OTC, Prescription), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Xerostomia Therapeutics market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Xerostomia Therapeutics market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Xerostomia Therapeutics market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Xerostomia Therapeutics market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Xerostomia Therapeutics market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Xerostomia Therapeutics market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Xerostomia Therapeutics, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Xerostomia Therapeutics market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Xerostomia Therapeutics market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
OTC
Prescription
Market segment by Application
Hospital
Clinic
Other
Global Xerostomia Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
GlaxoSmithKline plc
Church & Dwight Co., Inc.
Colgate-Palmolive Company
Hikma Pharmaceuticals PLC
Pendopharm
Sun Pharmaceuticals Industries Ltd.
Lupin Pharmaceuticals, Inc.
Pfizer, Inc.
Parnell Pharmaceuticals, Inc.
Acacia Pharma
OraCoat
Outline of Major Chapters:
Chapter 1: Introduces the definition of Xerostomia Therapeutics, market overview.
Chapter 2: Global Xerostomia Therapeutics market size in revenue and volume.
Chapter 3: Detailed analysis of Xerostomia Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Xerostomia Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Xerostomia Therapeutics capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Xerostomia Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Xerostomia Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Xerostomia Therapeutics Overall Market Size
2.1 Global Xerostomia Therapeutics Market Size: 2022 VS 2029
2.2 Global Xerostomia Therapeutics Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Xerostomia Therapeutics Sales: 2018-2029
3 Company Landscape
3.1 Top Xerostomia Therapeutics Players in Global Market
3.2 Top Global Xerostomia Therapeutics Companies Ranked by Revenue
3.3 Global Xerostomia Therapeutics Revenue by Companies
3.4 Global Xerostomia Therapeutics Sales by Companies
3.5 Global Xerostomia Therapeutics Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Xerostomia Therapeutics Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Xerostomia Therapeutics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Xerostomia Therapeutics Players in Global Market
3.8.1 List of Global Tier 1 Xerostomia Therapeutics Companies
3.8.2 List of Global Tier 2 and Tier 3 Xerostomia Therapeutics Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Xerostomia Therapeutics Market Size Markets, 2022 & 2029
4.1.2 OTC
4.1.3 Prescription
4.2 By Type – Global Xerostomia Therapeutics Revenue & Forecasts
4.2.1 By Type – Global Xerostomia Therapeutics Revenue, 2018-2023
4.2.2 By Type – Global Xerostomia Therapeutics Revenue, 2024-2029
4.2.3 By Type – Global Xerostomia Therapeutics Revenue Market Share, 2018-2029
4.3 By Type – Global Xerostomia Therapeutics Sales & Forecasts
4.3.1 By Type – Global Xerostomia Therapeutics Sales, 2018-2023
4.3.2 By Type – Global Xerostomia Therapeutics Sales, 2024-2029
4.3.3 By Type – Global Xerostomia Therapeutics Sales Market Share, 2018-2029
4.4 By Type – Global Xerostomia Therapeutics Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Xerostomia Therapeutics Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application – Global Xerostomia Therapeutics Revenue & Forecasts
5.2.1 By Application – Global Xerostomia Therapeutics Revenue, 2018-2023
5.2.2 By Application – Global Xerostomia Therapeutics Revenue, 2024-2029
5.2.3 By Application – Global Xerostomia Therapeutics Revenue Market Share, 2018-2029
5.3 By Application – Global Xerostomia Therapeutics Sales & Forecasts
5.3.1 By Application – Global Xerostomia Therapeutics Sales, 2018-2023
5.3.2 By Application – Global Xerostomia Therapeutics Sales, 2024-2029
5.3.3 By Application – Global Xerostomia Therapeutics Sales Market Share, 2018-2029
5.4 By Application – Global Xerostomia Therapeutics Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Xerostomia Therapeutics Market Size, 2022 & 2029
6.2 By Region – Global Xerostomia Therapeutics Revenue & Forecasts
6.2.1 By Region – Global Xerostomia Therapeutics Revenue, 2018-2023
6.2.2 By Region – Global Xerostomia Therapeutics Revenue, 2024-2029
6.2.3 By Region – Global Xerostomia Therapeutics Revenue Market Share, 2018-2029
6.3 By Region – Global Xerostomia Therapeutics Sales & Forecasts
6.3.1 By Region – Global Xerostomia Therapeutics Sales, 2018-2023
6.3.2 By Region – Global Xerostomia Therapeutics Sales, 2024-2029
6.3.3 By Region – Global Xerostomia Therapeutics Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Xerostomia Therapeutics Revenue, 2018-2029
6.4.2 By Country – North America Xerostomia Therapeutics Sales, 2018-2029
6.4.3 US Xerostomia Therapeutics Market Size, 2018-2029
6.4.4 Canada Xerostomia Therapeutics Market Size, 2018-2029
6.4.5 Mexico Xerostomia Therapeutics Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Xerostomia Therapeutics Revenue, 2018-2029
6.5.2 By Country – Europe Xerostomia Therapeutics Sales, 2018-2029
6.5.3 Germany Xerostomia Therapeutics Market Size, 2018-2029
6.5.4 France Xerostomia Therapeutics Market Size, 2018-2029
6.5.5 U.K. Xerostomia Therapeutics Market Size, 2018-2029
6.5.6 Italy Xerostomia Therapeutics Market Size, 2018-2029
6.5.7 Russia Xerostomia Therapeutics Market Size, 2018-2029
6.5.8 Nordic Countries Xerostomia Therapeutics Market Size, 2018-2029
6.5.9 Benelux Xerostomia Therapeutics Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Xerostomia Therapeutics Revenue, 2018-2029
6.6.2 By Region – Asia Xerostomia Therapeutics Sales, 2018-2029
6.6.3 China Xerostomia Therapeutics Market Size, 2018-2029
6.6.4 Japan Xerostomia Therapeutics Market Size, 2018-2029
6.6.5 South Korea Xerostomia Therapeutics Market Size, 2018-2029
6.6.6 Southeast Asia Xerostomia Therapeutics Market Size, 2018-2029
6.6.7 India Xerostomia Therapeutics Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Xerostomia Therapeutics Revenue, 2018-2029
6.7.2 By Country – South America Xerostomia Therapeutics Sales, 2018-2029
6.7.3 Brazil Xerostomia Therapeutics Market Size, 2018-2029
6.7.4 Argentina Xerostomia Therapeutics Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Xerostomia Therapeutics Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Xerostomia Therapeutics Sales, 2018-2029
6.8.3 Turkey Xerostomia Therapeutics Market Size, 2018-2029
6.8.4 Israel Xerostomia Therapeutics Market Size, 2018-2029
6.8.5 Saudi Arabia Xerostomia Therapeutics Market Size, 2018-2029
6.8.6 UAE Xerostomia Therapeutics Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 GlaxoSmithKline plc
7.1.1 GlaxoSmithKline plc Company Summary
7.1.2 GlaxoSmithKline plc Business Overview
7.1.3 GlaxoSmithKline plc Xerostomia Therapeutics Major Product Offerings
7.1.4 GlaxoSmithKline plc Xerostomia Therapeutics Sales and Revenue in Global (2018-2023)
7.1.5 GlaxoSmithKline plc Key News & Latest Developments
7.2 Church & Dwight Co., Inc.
7.2.1 Church & Dwight Co., Inc. Company Summary
7.2.2 Church & Dwight Co., Inc. Business Overview
7.2.3 Church & Dwight Co., Inc. Xerostomia Therapeutics Major Product Offerings
7.2.4 Church & Dwight Co., Inc. Xerostomia Therapeutics Sales and Revenue in Global (2018-2023)
7.2.5 Church & Dwight Co., Inc. Key News & Latest Developments
7.3 Colgate-Palmolive Company
7.3.1 Colgate-Palmolive Company Company Summary
7.3.2 Colgate-Palmolive Company Business Overview
7.3.3 Colgate-Palmolive Company Xerostomia Therapeutics Major Product Offerings
7.3.4 Colgate-Palmolive Company Xerostomia Therapeutics Sales and Revenue in Global (2018-2023)
7.3.5 Colgate-Palmolive Company Key News & Latest Developments
7.4 Hikma Pharmaceuticals PLC
7.4.1 Hikma Pharmaceuticals PLC Company Summary
7.4.2 Hikma Pharmaceuticals PLC Business Overview
7.4.3 Hikma Pharmaceuticals PLC Xerostomia Therapeutics Major Product Offerings
7.4.4 Hikma Pharmaceuticals PLC Xerostomia Therapeutics Sales and Revenue in Global (2018-2023)
7.4.5 Hikma Pharmaceuticals PLC Key News & Latest Developments
7.5 Pendopharm
7.5.1 Pendopharm Company Summary
7.5.2 Pendopharm Business Overview
7.5.3 Pendopharm Xerostomia Therapeutics Major Product Offerings
7.5.4 Pendopharm Xerostomia Therapeutics Sales and Revenue in Global (2018-2023)
7.5.5 Pendopharm Key News & Latest Developments
7.6 Sun Pharmaceuticals Industries Ltd.
7.6.1 Sun Pharmaceuticals Industries Ltd. Company Summary
7.6.2 Sun Pharmaceuticals Industries Ltd. Business Overview
7.6.3 Sun Pharmaceuticals Industries Ltd. Xerostomia Therapeutics Major Product Offerings
7.6.4 Sun Pharmaceuticals Industries Ltd. Xerostomia Therapeutics Sales and Revenue in Global (2018-2023)
7.6.5 Sun Pharmaceuticals Industries Ltd. Key News & Latest Developments
7.7 Lupin Pharmaceuticals, Inc.
7.7.1 Lupin Pharmaceuticals, Inc. Company Summary
7.7.2 Lupin Pharmaceuticals, Inc. Business Overview
7.7.3 Lupin Pharmaceuticals, Inc. Xerostomia Therapeutics Major Product Offerings
7.7.4 Lupin Pharmaceuticals, Inc. Xerostomia Therapeutics Sales and Revenue in Global (2018-2023)
7.7.5 Lupin Pharmaceuticals, Inc. Key News & Latest Developments
7.8 Pfizer, Inc.
7.8.1 Pfizer, Inc. Company Summary
7.8.2 Pfizer, Inc. Business Overview
7.8.3 Pfizer, Inc. Xerostomia Therapeutics Major Product Offerings
7.8.4 Pfizer, Inc. Xerostomia Therapeutics Sales and Revenue in Global (2018-2023)
7.8.5 Pfizer, Inc. Key News & Latest Developments
7.9 Parnell Pharmaceuticals, Inc.
7.9.1 Parnell Pharmaceuticals, Inc. Company Summary
7.9.2 Parnell Pharmaceuticals, Inc. Business Overview
7.9.3 Parnell Pharmaceuticals, Inc. Xerostomia Therapeutics Major Product Offerings
7.9.4 Parnell Pharmaceuticals, Inc. Xerostomia Therapeutics Sales and Revenue in Global (2018-2023)
7.9.5 Parnell Pharmaceuticals, Inc. Key News & Latest Developments
7.10 Acacia Pharma
7.10.1 Acacia Pharma Company Summary
7.10.2 Acacia Pharma Business Overview
7.10.3 Acacia Pharma Xerostomia Therapeutics Major Product Offerings
7.10.4 Acacia Pharma Xerostomia Therapeutics Sales and Revenue in Global (2018-2023)
7.10.5 Acacia Pharma Key News & Latest Developments
7.11 OraCoat
7.11.1 OraCoat Company Summary
7.11.2 OraCoat Business Overview
7.11.3 OraCoat Xerostomia Therapeutics Major Product Offerings
7.11.4 OraCoat Xerostomia Therapeutics Sales and Revenue in Global (2018-2023)
7.11.5 OraCoat Key News & Latest Developments
8 Global Xerostomia Therapeutics Production Capacity, Analysis
8.1 Global Xerostomia Therapeutics Production Capacity, 2018-2029
8.2 Xerostomia Therapeutics Production Capacity of Key Manufacturers in Global Market
8.3 Global Xerostomia Therapeutics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Xerostomia Therapeutics Supply Chain Analysis
10.1 Xerostomia Therapeutics Industry Value Chain
10.2 Xerostomia Therapeutics Upstream Market
10.3 Xerostomia Therapeutics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Xerostomia Therapeutics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer